The Fred & Pamela Buffett Cancer Center – Nebraska Medical Center will be the first institution in a six-state region to offer proton therapy, beginning in spring 2027.
The Fred & Pamela Buffett Cancer Center – Nebraska Medical Center is one of only 73 cancer centers in the U.S. with the special National Cancer Institute (NCI) designation.
Every cancer treatment available today started as a clinical trial. For patients facing cancer, choosing a center deeply involved in research can mean access to tomorrow’s treatments today.
Cancer screenings are one of the most powerful forms of self-care. Screening empowers both you and your doctor by detecting cancer at its earliest and most treatable stage.
When facing a cancer diagnosis, many patients assume one doctor will map out their care and treatment plan. But the most effective cancer care often comes from a team approach.
Wendy Wessling began her cancer journey over a decade ago. With her husband Tom and four children by her side, Wessling embarked on a journey she never thought she’d have to face.
Bernie Ketterl always enjoyed helping others by regularly donating blood. He didn’t realize that this simple act of kindness would also help save his life.
When Jeff Kramer felt a persistent backache in February 2023, he expected it to resolve on its own. The 63-year-old endured the discomfort for months before seeking care, which led to a shocking discovery: kidney cancer.
The Fred & Pamela Buffett Cancer Center is a recognized leader in cellular therapies such as stem cell transplants, bone marrow transplants and CAR T-cell therapy, treatments that harness the body’s own cells to fight cancer.
While traditional screening works well, it only detects one type of cancer. Cancer centers are now exploring new technology that can screen for multiple cancers at once.
